ROBINSON CHANDLER (Chief Executive Officer) exercised options at MONOPAR THERAPEUTICS
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 7/2/2025ACC: 0001437749-25-021994
DirectorOfficer10% Owner· Chief Executive Officer
Since Aug 2018
-5.87K
Net shares
Net seller
$209.8K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
13.34K acquired · 19.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.34K
Price / share
—
Trade value
—
% of position
20.2%
6/30/2025
65.99K→79.34K
Common Stock
Direct
Shares
−5.87K
Price / share
$35.78
Trade value
$209.85K
% of position
7.4%
6/30/2025
79.34K→73.47K
Total
Net shares
+7.48K
Net value
-$209.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2025 | M · Option Exercise | +13.34K | — | — | 20.2% | 65.99K | 79.34K |
| Common Stock Direct | 6/30/2025 | F · Tax Withholding | −5.87K | $35.78 | $209.85K | 7.4% | 79.34K | 73.47K |
| Total | +7.48K | -$209.85K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
13.34K shares
Shares
−13.34K
Strike price
Held after
81.33K
Exercisable
—
6/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock13.34K shares | 6/30/2025 | M · Option Exercise | −13.34K | — | 81.33K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned822.25K
Total
822.25K indirect822.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 822.25K | Indirect |
| Total | 822.25K | 822.25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported